REATA PHARMACEUTICALS INC Operating Lease, Expense
REATA PHARMACEUTICALS INC reported Operating Lease, Expense of $4.40 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2023-08-08
- REATA PHARMACEUTICALS INC operating lease, expense for the quarter ending 2023-06-30 was $4.40M, a 2.33% increase year-over-year.
- REATA PHARMACEUTICALS INC operating lease, expense for the quarter ending 2023-03-31 was $4.30M, a 0.00% change year-over-year.
- REATA PHARMACEUTICALS INC operating lease, expense for the quarter ending 2022-12-31 was $4.30M, a 258.33% increase year-over-year.
- REATA PHARMACEUTICALS INC operating lease, expense for the quarter ending 2022-09-30 was $4.40M, a 450.00% increase year-over-year.
- REATA PHARMACEUTICALS INC operating lease, expense for fiscal 2022 was $17.30M, a 380.56% increase from fiscal 2021.
- REATA PHARMACEUTICALS INC operating lease, expense for fiscal 2021 was $3.60M, a 5.88% increase from fiscal 2020.
- REATA PHARMACEUTICALS INC operating lease, expense for fiscal 2020 was $3.40M, a 0.00% change from fiscal 2019.
- REATA PHARMACEUTICALS INC operating lease, expense for fiscal 2019 was $3.40M, a 466.67% increase from fiscal 2018.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2023-06-30 | $4.40M 10-Q · filed 2023-08-08 | $8.70M 10-Q · filed 2023-08-08 | $13.00M derived: sum of 3 quarters · filed 2023-08-08 | $17.40M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | $4.30M 10-Q · filed 2023-05-10 | $8.60M derived: sum of 2 quarters · filed 2023-05-10 | $13.00M derived: sum of 3 quarters · filed 2023-05-10 | $17.30M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $8.70M derived: sum of 2 quarters · filed 2023-02-24 | $13.00M derived: sum of 3 quarters · filed 2023-08-08 | $17.30M 10-K · filed 2023-02-24 |
| 2022-09-30 | $4.40M 10-Q · filed 2022-11-08 | $8.70M derived: sum of 2 quarters · filed 2023-08-08 | $13.00M 10-Q · filed 2022-11-08 | $14.20M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-06-30 | $4.30M 10-Q · filed 2023-08-08 | $8.60M 10-Q · filed 2023-08-08 | $9.80M derived: sum of 3 quarters · filed 2023-08-08 | $10.60M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $4.30M 10-Q · filed 2023-05-10 | $5.50M derived: sum of 2 quarters · filed 2023-05-10 | $6.30M derived: sum of 3 quarters · filed 2023-05-10 | $7.10M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $2.00M derived: sum of 2 quarters · filed 2023-02-24 | $2.80M derived: sum of 3 quarters · filed 2023-02-24 | $3.60M 10-K · filed 2023-02-24 |
| 2021-09-30 | $800.00K 10-Q · filed 2022-11-08 | $1.60M derived: sum of 2 quarters · filed 2022-11-08 | $2.40M 10-Q · filed 2022-11-08 | $3.00M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $800.00K 10-Q · filed 2022-08-08 | $1.60M 10-Q · filed 2022-08-08 | $2.20M derived: sum of 3 quarters · filed 2023-02-24 | $3.20M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $800.00K 10-Q · filed 2022-05-10 | $1.40M derived: sum of 2 quarters · filed 2023-02-24 | $2.40M derived: sum of 3 quarters · filed 2023-02-24 | $3.40M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $1.60M derived: sum of 2 quarters · filed 2023-02-24 | $2.60M derived: sum of 3 quarters · filed 2023-02-24 | $3.40M 10-K · filed 2023-02-24 |
| 2020-09-30 | $1.00M 10-Q · filed 2020-11-09 | $2.00M derived: sum of 2 quarters · filed 2020-11-09 | $2.80M 10-Q · filed 2020-11-09 | $3.81M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $1.00M 10-Q · filed 2020-08-10 | $1.90M 10-Q · filed 2020-08-10 | $2.81M derived: sum of 3 quarters · filed 2022-02-28 | $3.72M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $900.00K 10-Q · filed 2020-05-11 | $1.81M derived: sum of 2 quarters · filed 2022-02-28 | $2.72M derived: sum of 3 quarters · filed 2022-02-28 | $3.64M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $911.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.82M derived: sum of 2 quarters · filed 2022-02-28 | $2.74M derived: sum of 3 quarters · filed 2022-02-28 | $3.40M 10-K · filed 2022-02-28 |
| 2019-09-30 | $911.00K 10-Q · filed 2019-11-12 | $1.83M derived: sum of 2 quarters · filed 2019-11-12 | $2.49M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $919.00K 10-Q · filed 2019-08-08 | $1.58M 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $663.00K 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | $600.00K 10-K · filed 2021-03-01 |